Robert S Clarke

US Patent:

20020039211, Apr 4, 2002

Filed:

May 8, 2001

Appl. No.:

09/851593

Inventors:

Tian Shen - Cupertino CA, US
Robert Clarke - Santa Clara CA, US
Thomas Roman - Fremont CA, US
David Upham - Sunnyvale CA, US
David Pechner - San Jose CA, US
Laurence Newell - Saratoga CA, US

International Classification:

H04B010/08
H04B010/00

US Classification:

359/110000, 359/154000

Abstract:

In an optical communication network, a variable rate or non-uniform input rate signal is converted to a “pseudo” signal comprising a uniform or standard data rate for the optical communication system. At the receiver, the original non-uniform rate signal is recovered. Non-uniform signals do not have data rates compatible with the standard transmission rate or rates of the transmission system in which they are to be transmitted. In one version, a “pseudo” signal is generated comprising a data transmission frame format including a payload portion comprising a plurality of subpackets comprising data of the original input signal, and stuff bytes, the stuff bytes comprising null data to fill unused parts of the payload portion.

US Patent:

20070053844, Mar 8, 2007

Filed:

May 18, 2006

Appl. No.:

11/419165

Inventors:

Wiwik Watanabe - Mountain View CA, US
Matthew Thomas - Cambridge MA, US
Jeffrey Katstra - Watertown MA, US
Robert Clarke - Canton MA, US

International Classification:

A61K 48/00
A61K 9/14
A61L 9/04

US Classification:

424046000, 514044000

Abstract:

Conductive formulations containing conductive agents, such as salts, ionic surfactants, or other substances that are in an ionized state or easily ionized in an aqueous or organic solvent environment, and methods of use, have been developed. One or more active agents, such as antivirals, antimicrobials, anti-inflammatories, proteins or peptides, may optionally be included with the formulation. The active agent may be administered with or incorporated into the formulation, or may be administered after the conductive formulation is administered. When applied to mucosal lining fluids, the formulation alters the physical properties such as the surface tension, surface elasticity, and bulk viscosity of the mucosal lining. The formulation is administered in an amount sufficient to alter biophysical properties in the mucosal linings of the body. The formulations may be administered for several different purposes: reducing the spreading of infectious diseases, both viral and bacterial, such as SARS, influenza, tuberculosis, and RSV in humans and hoof and mouth disease in cloven-tooted animals; minimizing ambient contamination due to particle formation during breathing, coughing, sneezing, or talking which is particularly important in the clean room applications; decreasing or preventing the occurrence of obstructive sleep apnea and some cases of irritable bowel syndrome; and controlling the uptake kinetics of drug molecules and pathogens.

US Patent:

D2729970, Mar 13, 1984

Filed:

May 8, 1981

Appl. No.:

6/262203

Inventors:

Duane L. Anderson - Grover City CA
Robert S. Clarke - Arroyo Grande CA
Lewis R. Morris - Grover City CA

Assignee:

First Champaign Corporation - Rantoul IL

US Classification:

D12116

US Patent:

20190267681, Aug 29, 2019

Filed:

May 9, 2019

Appl. No.:

16/407914

Inventors:

- Alameda CA, US
Michael John King - Oakland CA, US
Robert Lewis Clarke - Orinda CA, US
Stephen R. Clarke - Orinda CA, US
Michael David Hurwitz - Alameda CA, US

International Classification:

H01M 10/54
C25C 7/00
C25C 5/02
C25C 1/18
C25C 7/08
H01M 10/06
H01M 4/14

Abstract:

Lead from lead acid battery scrap is recovered in two separate production streams as clean grid lead and as high-purity lead without smelting. In preferred aspects, lead recovery is performed in a continuous process that uses an aqueous electroprocessing solvent and electro-refining. Spent electroprocessing solvent and/or base utilized to treat lead paste from the lead acid battery scrap can be recycled to the recovery process.

US Patent:

20170352927, Dec 7, 2017

Filed:

May 13, 2015

Appl. No.:

15/527749

Inventors:

- Alameda CA, US
Michael John King - Oakland CA, US
Robert Lewis Clarke - Orinda CA, US
Stephen R. Clarke - Orinda CA, US
Michael David Hurwitz - Alameda CA, US

International Classification:

H01M 10/54
H01M 10/06

Abstract:

Lead from lead acid battery scrap is recovered in two separate production streams as clean grid lead and as high-purity lead without smelting. In preferred aspects, lead recovery is performed in a continuous process that uses an aqueous electroprocessing solvent and electro-refining. Spent electroprocessing solvent and/or base utilized to treat lead paste from the lead acid battery scrap can be recycled to the recovery process.